Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In terms of Regulations 47 of SEBI(LODR) Regulations, 2015 the company has published the audited Financial Results for the quarter and year ended March 31,2022 in ''Western Times'' (English) edition dated Monday, May 23,2022 & in Western Times'' (Gujarati) edition dated Monday, May 23,2022. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in the above mentioned newspapers. Kindly take the same on record and acknowledge receipt.
23-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Board recommends Dividend

Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2022, inter alia, has recommended dividend for Financial Year ended March 31, 2022 of Rs. 5.00/- (Rupees Five only) i.e. @ 50% per equity share having face value of Rs. 10/-, aggregating to Rs. 460.02 lacs. The payment is subject to the approval of shareholders at the ensuing AGM.
23-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Corporate Action-Board to consider Dividend

2. Recommended dividend for Financial Year ended 31.03.2022 of Rs.5.00/- (Rupees Five only) i.e. @ 50% per equity share having face value of Rs.10/-, aggregating to Rs.460.02 lacs. The payment is subject to the approval of shareholders at the ensuing AGM.
21-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Corporate Action -Fixes Book Closure For Dividend

5. Confirmed the time, and date of the 52nd Annual General Meeting which will be held on Monday, 19th September, 2022 at 12 Noon. 6. Closure of Register of Members and Share Transfer Books from Monday, 12th September, 2022 to Monday, 19th September, 2022 (both days inclusive) for the purpose of 52nd Annual General Meeting and payment of dividend for the financial year 2021-22, if approved at the ensuing Annual General Meeting.
21-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Financial Results 31.03.2022

1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2022. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2022 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2022 of Rs.5.00/- (Rupees Five only) i.e. @ 50% per equity share having face value of Rs.10/-, aggregating to Rs.460.02 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. 3. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2022-23. 4. Appointed CS Shirish Shetye (FCS 1926), or failing him, CS Aparna P. Joshi (FCS 7172) or failing her, CS Vaibhav S. Velankar (FCS 11448), designated partners of SAV & Associates LLP, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 52nd Annual General Meeting.
21-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of The Board Meeting

1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2022. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2022 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2022 of Rs.5.00/- (Rupees Five only) i.e. @ 50% per equity share having face value of Rs.10/-, aggregating to Rs.460.02 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. 3. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2022-23. 4. Appointed CS Shirish Shetye (FCS 1926), or failing him, CS Aparna P. Joshi (FCS 7172) or failing her, CS Vaibhav S. Velankar (FCS 11448), designated partners of SAV & Associates LLP, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 52nd Annual General Meeting.
21-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Notice of Postal Ballot is being published in terms of Regulation 47 of the SEBI (LODR) Regulations, 2015, in the 'Indian Express' (English) Newspaper edition dated May 18, 2022 and in ''Financial Express'' (Gujarati) edition dated May 18, 2022. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in above mentioned newspapers Kindly take the same on record.
18-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Receipt of add on approval for our drug VIRALEX for the treatment of Influenza and other Acute Viral Respiratory Infections (AVRI), Mucocutaneous herpes, Genital wart and Subacute Sclerosing Panencephalitis (SSPE).
18-05-2022
Bigul

THEMIS MEDICARE LTD. - 530199 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Dear Sir/Madam, This is further to our letter dated 10.05.2022, In terms of Regulation 30 of the SEBI Listing Regulations, we enclose a copy of Postal Ballot notice seeking the approval of members for the resolutions contained in the notice. In compliance with Ministry of Corporate Affairs Circulars this postal ballot notice is being sent only through electronic mode to those members whose e-mail addresses are registered with the Company/Depositories and whose names are recorded in the Register of Members of the Company or in the Register of Beneficial Owners maintained by the Depositories as on the Cut-off date i.e. 11.05.2022 ('Cut-off date'). The Company has engaged the services of Central Depository Services (India) Limited ('CDSL') to provide e-voting facility to its Members. The e-voting period commences from 9.00 a.m. (IST) on Thursday, 19.05.2022 and ends at 5.00 p.m. (IST) on Friday, 17.06.2022. The e-voting module shall be disabled by CDSL thereafter.
17-05-2022
Next Page
Close

Let's Open Free Demat Account